birth defect screening

The Triple Test: Comprehensive Screening for Maternal and Fetal Health is a non-invasive prenatal blood test that evaluates three key biomarkers—AFP, hCG, and estriol—to assess the risk of fetal chromosomal abnormalities such as Down syndrome and neural tube defects.

Sample Type : Serum

Methodology : Enzyme-immunoassay

TAT : 3 Days